William S. Comanor

Pharmaceutical Pricing and R&D as a Global Public Good.

This paper examines the international variation in the prices of branded pharmaceuticals. We consider short-run profits, or quasi-rents, as representing each country's contribution toward the global public good of therapeutic information embodied in new pharmaceuticals. We charac...